These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12386503)

  • 1. Use of vasopressor agents in critically ill patients.
    Kellum JA; Pinsky MR
    Curr Opin Crit Care; 2002 Jun; 8(3):236-41. PubMed ID: 12386503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoactive drugs in circulatory shock.
    Hollenberg SM
    Am J Respir Crit Care Med; 2011 Apr; 183(7):847-55. PubMed ID: 21097695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Clinical Review of Vasopressors in Emergency Medicine.
    Stampfl M; DeBlieux P
    J Emerg Med; 2024 Jul; 67(1):e31-e41. PubMed ID: 38789351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction.
    Levy B; Clere-Jehl R; Legras A; Morichau-Beauchant T; Leone M; Frederique G; Quenot JP; Kimmoun A; Cariou A; Lassus J; Harjola VP; Meziani F; Louis G; Rossignol P; Duarte K; Girerd N; Mebazaa A; Vignon P;
    J Am Coll Cardiol; 2018 Jul; 72(2):173-182. PubMed ID: 29976291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholamine Vasopressor Support Sparing Strategies in Vasodilatory Shock.
    Buckley MS; Barletta JF; Smithburger PL; Radosevich JJ; Kane-Gill SL
    Pharmacotherapy; 2019 Mar; 39(3):382-398. PubMed ID: 30506565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Push Dose Epinephrine Use in the Management of Hypotension During Critical Care Transport.
    Nawrocki PS; Poremba M; Lawner BJ
    Prehosp Emerg Care; 2020; 24(2):188-195. PubMed ID: 30808241
    [No Abstract]   [Full Text] [Related]  

  • 7. Intensity of Vasopressor Therapy for Septic Shock and the Risk of In-Hospital Death.
    Brand DA; Patrick PA; Berger JT; Ibrahim M; Matela A; Upadhyay S; Spiegler P
    J Pain Symptom Manage; 2017 May; 53(5):938-943. PubMed ID: 28062334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock.
    Morales DL; Gregg D; Helman DN; Williams MR; Naka Y; Landry DW; Oz MC
    Ann Thorac Surg; 2000 Jan; 69(1):102-6. PubMed ID: 10654495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines.
    Delle Karth G; Buberl A; Geppert A; Neunteufl T; Huelsmann M; Kopp C; Nikfardjam M; Berger R; Heinz G
    Acta Anaesthesiol Scand; 2003 Nov; 47(10):1251-6. PubMed ID: 14616323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of vasopressors and inotropics in cardiogenic shock].
    Lemm H; Dietz S; Janusch M; Buerke M
    Herz; 2017 Feb; 42(1):3-10. PubMed ID: 28101622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study.
    Levy B; Perez P; Perny J; Thivilier C; Gerard A
    Crit Care Med; 2011 Mar; 39(3):450-5. PubMed ID: 21037469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Refractory Vasodilatory Shock.
    Jentzer JC; Vallabhajosyula S; Khanna AK; Chawla LS; Busse LW; Kashani KB
    Chest; 2018 Aug; 154(2):416-426. PubMed ID: 29329694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: profound hypotension associated with labetalol therapy in a patient with cerebral aneurysms and subarachnoid hemorrhage.
    Jivraj S; Mazer CD; Baker AJ; Choi M; Hare GM
    Can J Anaesth; 2006 Jul; 53(7):678-83. PubMed ID: 16803915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
    Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
    Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vasopressin on sublingual microcirculation in a patient with distributive shock.
    Dubois MJ; De Backer D; Creteur J; Anane S; Vincent JL
    Intensive Care Med; 2003 Jun; 29(6):1020-1023. PubMed ID: 12736775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of dopamine and norepinephrine in shock.
    Tomoda H
    N Engl J Med; 2010 Jun; 362(24):2329-30; author reply 2330-1. PubMed ID: 20560181
    [No Abstract]   [Full Text] [Related]  

  • 18. Dear vasopressin, where is your place in septic shock?
    Duenser MW; Hasibeder WR
    Crit Care; 2005 Apr; 9(2):134-5. PubMed ID: 15774061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of midodrine and methylene blue as catecholamine-sparing agents in intensive care unit patients with shock.
    Tchen S; Sullivan JB
    J Crit Care; 2020 Jun; 57():148-156. PubMed ID: 32145658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of parameters associated with hypotension requiring vasopressor support after carotid angioplasty and stenting.
    Trocciola SM; Chaer RA; Lin SC; Ryer EJ; De Rubertis B; Morrissey NJ; McKinsey J; Kent KC; Faries PL
    J Vasc Surg; 2006 Apr; 43(4):714-20. PubMed ID: 16616226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.